{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:04:37Z","timestamp":1792123477496,"version":"4.4.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T00:00:00Z","timestamp":1530230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Heart Fail Rep"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11897-018-0396-6","type":"journal-article","created":{"date-parts":[[2018,6,29]],"date-time":"2018-06-29T04:17:17Z","timestamp":1530245837000},"page":"214-223","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identifying and Managing Hibernating Myocardium: What\u2019s New and What Remains Unknown?"],"prefix":"10.1007","volume":"15","author":[{"given":"Matthew J.","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,29]]},"reference":[{"key":"396_CR1","unstructured":"Donkor A, McDonagh T, Cleland JG, Hardman S. National Heart Failure Audit April 2014\u2013March 2015. 2016. 1\u201372."},{"key":"396_CR2","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.jacc.2016.06.061","volume":"68","author":"I Johansson","year":"2016","unstructured":"\u2022 Johansson I, Dahlstr\u00f6m U, Edner M, N\u00e4sman P, Ryd\u00e9n L, Norhammar A. Prognostic implications of type 2 diabetes mellitus in ischemic and nonischemic heart failure. J Am Coll Cardiol. 2016;68:1404\u201316. Contemporary data demonstrating the ongoing significant mortality of ischaemic heart failure.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","volume":"30","author":"BA Bart","year":"1997","unstructured":"Bart BA, Shaw LK, McCants CB, Fortin DF, Lee KL, Califf RM, et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. JACC. 1997;30:1002\u20138.","journal-title":"JACC"},{"key":"396_CR4","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/jama.296.18.2217","volume":"296","author":"M Gheorghiade","year":"2006","unstructured":"Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O\u2019Connor CM, She L, et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA. 2006;296:2217\u201326.","journal-title":"JAMA"},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1053\/euhj.2000.2289","volume":"22","author":"KF Fox","year":"2001","unstructured":"Fox KF, Cowie MR, Wood DA, Coats AJ, Gibbs JS, Underwood SR, et al. Coronary artery disease as the cause of incident heart failure in the population. Eur Heart J. 2001;22:228\u201336.","journal-title":"Eur Heart J"},{"key":"396_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jacc.2008.08.072","volume":"53","author":"JD Flaherty","year":"2009","unstructured":"Flaherty JD, Bax JJ, De Luca L, et al. Acute heart failure syndromes in patients with coronary artery disease. JACC. 2009;53:254\u201363.","journal-title":"JACC"},{"key":"396_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0735-1097(84)80347-2","volume":"3","author":"B Brundage","year":"1984","unstructured":"Brundage B, Massie B, Botvinick E. Improved regional ventricular function after successful surgical revascularization. J Am Coll Cardiol. 1984;3:902\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0002-8703(89)90685-6","volume":"117","author":"SH Rahimtoola","year":"1989","unstructured":"Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211\u201321.","journal-title":"Am Heart J"},{"key":"396_CR9","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1161\/01.CIR.58.6.1154","volume":"58","author":"BM Massie","year":"1978","unstructured":"Massie BM, Botvinick EH, Brundage BH, Greenberg B, Shames D, Gelberg H. Relationship of regional myocardial perfusion to segmental wall motion: a physiologic basis for understanding the presence and reversibility of asynergy. Circulation. 1978;58:1154\u201363.","journal-title":"Circulation"},{"key":"396_CR10","first-page":"942","volume":"38","author":"AK McDiarmid","year":"2016","unstructured":"\u2022 McDiarmid AK, Pellicori P, Cleland JG, Plein S. Taxonomy of segmental myocardial systolic dysfunction. Eur Heart J. 2016;38:942\u201354. The authors neatly summarise methods of discriminating myocardial pathology using contemporary imaging modalities.","journal-title":"Eur Heart J"},{"key":"396_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1161\/01.RES.0000076892.18394.B6","volume":"92","author":"SJ Kim","year":"2003","unstructured":"Kim SJ. Persistent stunning induces myocardial hibernation and protection: flow\/function and metabolic mechanisms. Circ Res. 2003;92:1233\u20139.","journal-title":"Circ Res"},{"key":"396_CR12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1161\/01.CIR.87.5.1513","volume":"87","author":"JL Vanoverschelde","year":"1993","unstructured":"Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, et al. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513\u201323.","journal-title":"Circulation"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.carpath.2014.01.003","volume":"23","author":"F Verheyen","year":"2014","unstructured":"Verheyen F, Racz R, Borgers M, Driesen RB, Lenders MH, Flameng WJ. Chronic hibernating myocardium in sheep can occur without degenerating events and is reversed after revascularization. Cardiovasc Pathol. 2014;23:160\u20138.","journal-title":"Cardiovasc Pathol"},{"key":"396_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/hrt.81.4.404","volume":"81","author":"CA Rinaldi","year":"1999","unstructured":"Rinaldi CA, Masani ND, Linka AZ, Hall RJ. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning? Heart. 1999;81:404\u201311.","journal-title":"Heart"},{"key":"396_CR15","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.2215\/CJN.04470709","volume":"4","author":"JO Burton","year":"2009","unstructured":"Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced repetitive myocardial injury results in global and segmental reduction in systolic cardiac function. Clin J Am Soc Nephrol. 2009;4:1925\u201331.","journal-title":"Clin J Am Soc Nephrol"},{"key":"396_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/0735-1097(95)80005-2","volume":"26","author":"P Marzullo","year":"1995","unstructured":"Marzullo P, Parodi O, Sambuceti G, Giorgetti A, Picano E, Gimelli A, et al. Residual coronary reserve identifies segmental viability in patients with wall motion abnormalities. J Am Coll Cardiol. 1995;26:342\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/1054-8807(93)90030-6","volume":"2","author":"M Borgers","year":"1993","unstructured":"Borgers M, Thon\u00e9 F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol. 1993;2:237\u201345.","journal-title":"Cardiovasc Pathol"},{"key":"396_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0735-1097(01)01766-1","volume":"39","author":"MG Gunning","year":"2002","unstructured":"Gunning MG, Kaprielian RR, Pepper J, Pennell DJ, Sheppard MN, Severs NJ, et al. The histology of viable and hibernating myocardium in relation to imaging characteristics. JACC. 2002;39:428\u201335.","journal-title":"JACC"},{"key":"396_CR19","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jacc.2014.11.040","volume":"65","author":"BJ Page","year":"2015","unstructured":"\u2022 Page BJ, Banas MD, Suzuki G, Weil BR, Young RF, Fallavollita JA, et al. Revascularization of chronic hibernating myocardium stimulates myocyte proliferation and partially reverses chronic adaptations to ischemia. J Am Coll Cardiol. 2015;65:684\u201397. The authors provide the first detailed description of the histopathological basis for prolonged recovery of function, utilising a swine model which also demonstrated experimentally inducible hibernation.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR20","doi-asserted-by":"publisher","first-page":"H836","DOI":"10.1152\/ajpheart.00540.2010","volume":"300","author":"MN Jameel","year":"2011","unstructured":"Jameel MN, Li Q, Mansoor A, Xiong Q, Swingen C, Zhang J. Long-term preservation of myocardial energetic in chronic hibernating myocardium. Am J Physiol Heart Circ Physiol. 2011;300:H836\u201344.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"396_CR21","doi-asserted-by":"publisher","first-page":"H2945","DOI":"10.1152\/ajpheart.00012.2007","volume":"293","author":"EO McFalls","year":"2007","unstructured":"McFalls EO, Kelly RF, Hu Q, Mansoor A, Lee J, Kuskowski M, et al. The energetic state within hibernating myocardium is normal during dobutamine despite inhibition of ATP-dependent potassium channel opening with glibenclamide. Am J Physiol Heart Circ Physiol. 2007;293:H2945\u201351.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/01.RES.0000184675.80217.9e","volume":"97","author":"VS Iyer","year":"2005","unstructured":"Iyer VS. Regional desensitization of \u03b2-adrenergic receptor signaling in swine with chronic hibernating myocardium. Circ Res. 2005;97:789\u201395.","journal-title":"Circ Res"},{"key":"396_CR23","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1161\/01.CIR.102.21.2599","volume":"102","author":"K Shan","year":"2000","unstructured":"Shan K, Bick RJ, Poindexter BJ, Nagueh SF, Shimoni S, Verani MS, et al. Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation. 2000;102:2599\u2013606.","journal-title":"Circulation"},{"key":"396_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12265-015-9625-5","volume":"8","author":"RW Colbert","year":"2015","unstructured":"Colbert RW, Holley CT, Stone LH, Crampton M, Adabag S, Garcia S, et al. The recovery of hibernating hearts lies on a spectrum: from bears in nature to patients with coronary artery disease. J Cardiovasc Transl Res. 2015;8:244\u201352.","journal-title":"J Cardiovasc Transl Res"},{"key":"396_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1476-7120-12-36","volume":"12","author":"PG J\u00f8rgensen","year":"2014","unstructured":"J\u00f8rgensen PG, Arnemo J, Swenson JE, Jensen JS, Galatius S, Frobert O. Low cardiac output as physiological phenomenon in hibernating, free-ranging Scandinavian brown bears (Ursus arctos)\u2014an observational study. Cardiovasc Ultrasound. 2014;12:125\u20136.","journal-title":"Cardiovasc Ultrasound"},{"key":"396_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/01.RES.0000138301.42713.18","volume":"95","author":"C Depre","year":"2004","unstructured":"Depre C, Kim S-J, John AS, Huang Y, Rimoldi OE, Pepper JR, et al. Program of cell survival underlying human and experimental hibernating myocardium. Circ Res. 2004;95:433\u201340.","journal-title":"Circ Res"},{"key":"396_CR27","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.freeradbiomed.2017.04.190","volume":"108","author":"S Masovic","year":"2017","unstructured":"Masovic S, Stancic A, Jankovic A, Buzadzic B, Otasevic V, Korac A, et al. A lesson from the oxidative metabolism of a hibernator\u2019s heart: strategy for cardioprotection. Free Radic Biol Med. 2017;108:S53.","journal-title":"Free Radic Biol Med"},{"key":"396_CR28","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF\/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240\u2013327.","journal-title":"Circulation"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1007\/s00330-013-2817-y","volume":"23","author":"YE Yoon","year":"2013","unstructured":"Yoon YE, Kitagawa K, Kato S, Nakajima H, Kurita T, Dohi K, et al. Prognostic value of unrecognised myocardial infarction detected by late gadolinium-enhanced MRI in diabetic patients with normal global and regional left ventricular systolic function. Eur Radiol. 2013;23:2101\u20138.","journal-title":"Eur Radiol"},{"key":"396_CR30","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJM200011163432003","volume":"343","author":"RJ Kim","year":"2000","unstructured":"Kim RJ, Wu E, Rafael A, Chen E-L, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445\u201353.","journal-title":"N Engl J Med"},{"key":"396_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1532-429X-13-35","volume":"13","author":"S Glaveckaite","year":"2011","unstructured":"Glaveckaite S, Valeviciene N, Palionis D, Skorniakov V, Celutkiene J, Tamosiunas A, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson. 2011;13:35.","journal-title":"J Cardiovasc Magn Reson"},{"key":"396_CR32","first-page":"494","volume":"5","author":"J Romero","year":"2012","unstructured":"Romero J, Xue X, Gonzalez W, Garcia MJ. CMR imaging assessing viability in patients with chronic ventricular dysfunction due to coronary artery disease. JCMG. 2012;5:494\u2013508.","journal-title":"JCMG"},{"key":"396_CR33","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","volume":"379","author":"JP Greenwood","year":"2012","unstructured":"Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453\u201360.","journal-title":"Lancet"},{"key":"396_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/S0735-1097(00)00525-8","volume":"35","author":"JM Cwajg","year":"2000","unstructured":"Cwajg JM, Cwajg E, Nagueh SF, He Z-X, Qureshi U, Olmos LI, et al. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation. JACC. 2000;35:1152\u201361.","journal-title":"JACC"},{"key":"396_CR35","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0002-9149(99)80284-7","volume":"76","author":"F Faletra","year":"1995","unstructured":"Faletra F, Crivellaro W, Pirelli S, Parodi O, De Chiara F, Cipriani M, et al. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior wall myocardial infarction. AJC. 1995;76:1002\u20136.","journal-title":"AJC"},{"key":"396_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0735-1097(95)00139-Q","volume":"26","author":"R Senior","year":"1995","unstructured":"Senior R, Lahiri A. Enhanced detection of myocardial ischemia by stress dobutamine echocardiography utilizing the \u201cbiphasic\u201d response of wall thickening during low and high dose dobutamine infusion. J Am Coll Cardiol. 1995;26:26\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10554-016-1048-0","volume":"33","author":"IM Abdelgawwad","year":"2017","unstructured":"Abdelgawwad IM. Prediction of left ventricular contractile recovery using tissue Doppler strain and strain rate measurements at rest in patients undergoing percutaneous coronary intervention. Int J Cardiovasc Imaging. 2017;33:643\u201351.","journal-title":"Int J Cardiovasc Imaging"},{"key":"396_CR38","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B Bruyne De","year":"2012","unstructured":"De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional flow reserve\u2013guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991\u20131001.","journal-title":"N Engl J Med"},{"key":"396_CR39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1161\/CIRCINTERVENTIONS.112.973081","volume":"6","author":"K Silva De","year":"2013","unstructured":"\u2022 De Silva K, Foster P, Guilcher A, et al. Coronary wave energy: a novel predictor of functional recovery after myocardial infarction. Circ Cardiovasc Interv. 2013;6:166\u201375. The first demonstration of the ability of invasive physiological indices to predict functional recovery in ischaemic left ventricular dysfunction, in this case following an acute coronary syndrome.","journal-title":"Circ Cardiovasc Interv"},{"key":"396_CR40","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1093\/eurheartj\/ehp313","volume":"30","author":"HS Lim","year":"2009","unstructured":"Lim HS, Yoon MH, Tahk SJ, Yang HM, Choi BJ, Choi SY, et al. Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction. Eur Heart J. 2009;30:2854\u201360.","journal-title":"Eur Heart J"},{"key":"396_CR41","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jcin.2014.04.009","volume":"7","author":"E Petrucci","year":"2014","unstructured":"Petrucci E, Balian V, Bocchieri A. Real-time assessment of myocardial viability in the catheterization laboratory using the intracoronary electrograms recorded by the PTCA guidewire in patients with left ventricular dysfunction: comparison with delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol Intv. 2014;7:988\u201396.","journal-title":"J Am Coll Cardiol Intv"},{"key":"396_CR42","first-page":"1503","volume":"356","author":"J O'Neill","year":"2017","unstructured":"O'Neill J, Hogarth AJ, Pearson I, Law H, Bowes R, Kidambi A, et al. Transcoronary pacing to assess myocardial viability prior to percutaneous coronary intervention: pilot study to assess feasibility. Catheter Cardiovasc Interv. 2017;356:1503\u20136.","journal-title":"Catheter Cardiovasc Interv"},{"key":"396_CR43","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","volume":"374","author":"EJ Velazquez","year":"2016","unstructured":"\u2022\u2022 Velazquez EJ, Lee KL, Jones RH, al-Khalidi HR, Hill JA, Panza JA, et al. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy. N Engl J Med. 2016;374:1511\u201320. This seminal trial demonstrated the benefit of surgical revascularisation in patients with ischaemic left ventricular dysfunction, leading to strengthening recommendations in current guidelines.","journal-title":"N Engl J Med"},{"key":"396_CR44","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","volume":"364","author":"EJ Velazquez","year":"2011","unstructured":"Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607\u201316.","journal-title":"N Engl J Med"},{"key":"396_CR45","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","volume":"60","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, et al. 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60:e44\u2013e164.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR46","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"S Windecker","year":"2014","unstructured":"Windecker S, Kolh P, Alfonso F, et al. 2014 ESC\/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35:2541\u2013619.","journal-title":"Eur Heart J"},{"key":"396_CR47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1536\/ihj.16-087","volume":"57","author":"Y Adachi","year":"2016","unstructured":"\u2022 Adachi Y, Sakakura K, Wada H, Funayama H, Umemoto T, Fujita H, et al. Determinants of left ventricular systolic function improvement following coronary artery revascularization in heart failure patients with reduced ejection fraction (HFrEF). Int Heart J. 2016;57:565\u201372. A retrospective analysis of functional recovery following revascularisation, demonstrating that revascularisation of CTOs by PCI was the most significant predictor.","journal-title":"Int Heart J"},{"key":"396_CR48","unstructured":"Perera D, Clayton T, Petrie MC, et al Percutaneous revascularization for ischemic ventricular dysfunction: rationale and design of the REVIVED-BCIS2 trial. JACC Heart Failure (In Press)."},{"key":"396_CR49","first-page":"1060","volume":"2","author":"G D'Egidio","year":"2009","unstructured":"D'Egidio G, Nichol G, Williams KA, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation. JCMG. 2009;2:1060\u20138.","journal-title":"JCMG"},{"key":"396_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0735-1097(99)00157-6","volume":"34","author":"JJ Bax","year":"1999","unstructured":"Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol. 1999;34:163\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR51","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1161\/01.CIR.100.12.1298","volume":"100","author":"H Samady","year":"1999","unstructured":"Samady H, Elefteriades JA, Abbott BG, Mattera JA, McPherson CA, Wackers FJT. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation. 1999;100:1298\u2013304.","journal-title":"Circulation"},{"key":"396_CR52","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10840-016-0219-1","volume":"48","author":"AA Hussein","year":"2017","unstructured":"\u2022 Hussein AA, Niekoop M, Dilsizian V, et al. Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment. J Interv Card Electrophysiol. 2017;48:247\u201354. The authors demonstrate the arrhythmogenic potential of hibernating myocardium, as a possible mechanism for increased mortality in those with non-revascualrised hibernating myocardium.","journal-title":"J Interv Card Electrophysiol"},{"key":"396_CR53","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1161\/hc3801.096335","volume":"104","author":"GD Veenhuyzen","year":"2001","unstructured":"Veenhuyzen GD, Singh SN, McAreavey D, Shelton BJ, Exner DV. Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation. 2001;104:1489\u201393.","journal-title":"Circulation"},{"key":"396_CR54","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","volume":"39","author":"KC Allman","year":"2002","unstructured":"Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR55","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.jacc.2007.09.006","volume":"50","author":"RSB Beanlands","year":"2007","unstructured":"Beanlands RSB, Nichol G, Huszti E, Humen D, Racine N, Freeman M, et al. F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease. J Am Coll Cardiol. 2007;50:2002\u201312.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR56","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/eurjhf\/hfq230","volume":"13","author":"JGF Cleland","year":"2011","unstructured":"Cleland JGF, Calvert M, Freemantle N, Arrow Y, Ball SG, Bonser RS, et al. The HEART failure revascularisation trial (HEART). Eur J Heart Fail. 2011;13:227\u201333.","journal-title":"Eur J Heart Fail"},{"key":"396_CR57","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","volume":"364","author":"RO Bonow","year":"2011","unstructured":"Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617\u201325.","journal-title":"N Engl J Med"},{"key":"396_CR58","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0735-1097(01)01250-5","volume":"37","author":"JA Fallavollita","year":"2001","unstructured":"Fallavollita JA, Logue M, Canty JM. Stability of hibernating myocardium in pigs with a chronic left anterior descending coronary artery stenosis: absence of progressive fibrosis in the setting of stable reductions in flow, function and coronary flow reserve. JACC. 2001;37:1989\u201395.","journal-title":"JACC"},{"key":"396_CR59","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0735-1097(98)00041-2","volume":"31","author":"ER Schwarz","year":"1998","unstructured":"Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, et al. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. JACC. 1998;31:1018\u201326.","journal-title":"JACC"},{"key":"396_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacc.2008.03.037","volume":"52","author":"N Beohar","year":"2008","unstructured":"Beohar N, Erdogan AK, Lee DC, Sabbah HN, Kern MJ, Teerlink J, et al. Acute heart failure syndromes and coronary perfusion. J Am Coll Cardiol. 2008;52:13\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"396_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.amjcard.2005.07.017","volume":"96","author":"M Gheorghiade","year":"2005","unstructured":"Gheorghiade M, Gattis Stough W, Adams KF Jr, Jaffe AS, Hasselblad V, O'Connor CM. The pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF). Am J Cardiol. 2005;96:18\u201325.","journal-title":"Am J Cardiol"},{"key":"396_CR62","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.cjca.2017.06.012","volume":"33","author":"Z JGE","year":"2017","unstructured":"\u2022 JGE Z, Liu PP, Erthal F, Dekemp RA, Wells G, O'Meara E, et al. N-terminal pro B-type natriuretic peptide and high-sensitivity cardiac troponin T levels are related to the extent of hibernating myocardium in patients with ischemic heart failure. Can J Cardiol. 2017;33:1478\u201388. Troponin levels in patients with ADHF are shown to be related to the extent of hibernating myocardium, but not to scar. This supports troponin as a useful marker of ongoing myocardial necrosis in this context.","journal-title":"Can J Cardiol"},{"key":"396_CR63","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa0706824","volume":"358","author":"WF Peacock","year":"2008","unstructured":"Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117\u201326.","journal-title":"N Engl J Med"},{"key":"396_CR64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jcin.2014.09.014","volume":"8","author":"LM McCormick","year":"2015","unstructured":"McCormick LM, Hoole SP, White PA, Read PA, Axell RG, Clarke SJ, et al. Pre-treatment with glucagon-like peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization. JACC Cardiovasc Interv. 2015;8:292\u2013301.","journal-title":"JACC Cardiovasc Interv"},{"key":"396_CR65","first-page":"709","volume":"5","author":"JP Ferreira","year":"2017","unstructured":"\u2022 Ferreira JP, Rossignol P, Demissei B, et al. Coronary angiography in worsening heart failure: determinants, findings and prognostic implications. Heart. 2017;5:709\u201312. This contemporary study demonstrates the continued under-utilisation of angiography in decompensated heart failure.","journal-title":"Heart"}],"container-title":["Current Heart Failure Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11897-018-0396-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-018-0396-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11897-018-0396-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T15:06:06Z","timestamp":1589900766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11897-018-0396-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,29]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1007\/s11897-018-0396-6","relation":{},"ISSN":["1546-9530","1546-9549"],"issn-type":[{"value":"1546-9530","type":"print"},{"value":"1546-9549","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,29]]},"assertion":[{"value":"29 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Matthew J. Ryan declares no potential conflicts of interest. Divaka Perera is Chief Investigator for the REVIVED-BCIS2 trial, a UK multicentre RCT of viability-guided percutaneous revascularisation in ischaemic left ventricular dysfunction.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}